[Epidemiology-etiology of Dilated Cardiomyopathy]
Overview
Authors
Affiliations
Among the cardiomyopathies,--dilated cardiomyopathy (dcm), hypertrophic cardiomyopathy, restrictive cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy--, dcm is the most frequent entity. Its prevalence in the United States amounts to 36 cases per 100,000 inhabitants, men being almost 3-fold more involved than women. The etiology of dcm is very heterogenous; 50% of the cases are due to idiopathic dcm whereas the other half comprises a broad spectrum of various etiologies such as myocarditis, ischemic heart disease, peripartal cardiomyopathy, hypertension, HIV infection, toxic cardiomyopathy and others. In 20 to 30% of the cases of idiopathic dcm a genetic transmission of the disease has been found. Another 20 to 30% of idiopathic dcm are associated with inflammatory and immunological phenomena. Infectious myocarditis with enteroviruses, especially with coxsackie-virus type B has been suggested to be an important trigger for an immune-mediated dcm. In both, familiar dcm and infection with coxsackie-virus B, an impairment of constituents of the myocardial cytoskeleton has been shown. This is regarded as a possible pathogenetic mechanism in the development of dcm.
Saha S, Singh P, Dutta A, Vaidya H, Chand Negi P, Sengupta S JACC Asia. 2023; 3(4):539-555.
PMID: 37614533 PMC: 10442885. DOI: 10.1016/j.jacasi.2023.06.001.
Federspiel J, Ramsthaler F, Kettner M, Mall G Rechtsmedizin (Berl). 2022; 33(2):125-131.
PMID: 35873498 PMC: 9297279. DOI: 10.1007/s00194-022-00587-9.
The MOGE(S) classification for cardiomyopathies: current status and future outlook.
Westphal J, Rigopoulos A, Bakogiannis C, Ludwig S, Mavrogeni S, Bigalke B Heart Fail Rev. 2017; 22(6):743-752.
PMID: 28721466 DOI: 10.1007/s10741-017-9641-4.
Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention.
Guo R, Nair S Biochim Biophys Acta Mol Basis Dis. 2017; 1863(8):2070-2077.
PMID: 28344129 PMC: 5475364. DOI: 10.1016/j.bbadis.2017.03.013.
Cost-effectiveness of pre-participation screening of athletes with ECG in Europe and Algeria.
Assanelli D, Levaggi R, Carre F, Sharma S, Deligiannis A, Mellwig K Intern Emerg Med. 2014; 10(2):143-50.
PMID: 25164412 DOI: 10.1007/s11739-014-1123-2.